author-photo

Hellmut Samonigg

Medical University of Graz
University of Graz

218

Papers

9929

Citations

Citation Trend

Filter By

Papers (152) Sort By

Journal Conference Others

Herausforderungen an eine Universität

2021
- Hellmut Samonigg
Show All
- Source
- Cite
- Save
Citations (0)
Prevalence of comorbidity in cancer patients scheduled for systemic anticancer treatment in Austria

2019 Memo – Magazine of European Medical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Impact of body mass index (BMI) on the efficacy of zoledronic acid in premenopausal patients with hormone receptor positive breast cancer: An analysis of the ABCSG-12 trial.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.

2017 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (29)
Correlation of loss of spinophilin expression with increased proliferation and viability as a prognostic factor in patients with hepatocellular carcinoma.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Down-regulation of KRAS-interacting miRNA-143 to predict prognosis and response to EGFR-targeted agents in colorectal cancer.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.

2017 Anticancer Research
Show All
- Source
- Cite
- Save
Citations (8)
A randomized, double-blind, placebo-controlled, multicenter, multinational, phase II trial of L-BLP25 in patients with colorectal carcinoma following R0/R1 hepatic metastasectomy.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
23 Risk stratification for venous thromboembolism in patients with testicular germ cell tumours

2016 European Urology Supplements
Show All
- Source
- Cite
- Save
Citations (4)
A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options

2015 Journal of Clinical Pathology
Show All
- Source
- Cite
- Save
Citations (6)